Literature DB >> 11118006

Subcellular localization, mobility, and kinetic activity of glucokinase in glucose-responsive insulin-secreting cells.

M Stubbs1, S Aiston, L Agius.   

Abstract

We investigated the subcellular localization, mobility, and activity of glucokinase in MIN6 cells, a glucose-responsive insulin-secreting beta-cell line. Glucokinase is present in the cytoplasm and a vesicular/granule compartment that is partially colocalized with insulin granules. The granular staining of glucokinase is preserved after permeabilization of the cells with digitonin. There was no evidence for changes in distribution of glucokinase between the cytoplasm and the granule compartment during incubation of the cells with glucose. The rate of release of glucokinase and of phosphoglucoisomerase from digitonin-permeabilized cells was slower when cells were incubated at an elevated glucose concentration (S0.5 approximately 15 mmol/l). This effect of glucose was counteracted by competitive inhibitors of glucokinase (5-thioglucose and mannoheptulose) but was unaffected by fructose analogs and may be due to changes in cell shape or conformation of the cytoskeleton that are secondary to glucose metabolism. Based on the similar release of glucokinase and phosphoglucoisomerase, we found no evidence for specific binding of cytoplasmic digitonin-extractable glucokinase. The affinity of beta-cells for glucose is slightly lower than that in cell extracts and, unlike that in hepatocytes, is unaffected by fructose, tagatose, or a high-K+ medium, which is consistent with the lack of change in glucokinase distribution or release. We conclude that glucokinase is present in two locations, cytoplasm and the granular compartment, and that it does not translocate between them. This conclusion is consistent with the lack of adaptive changes in the glucose phosphorylation affinity. The glucokinase activity associated with the insulin granules may have a role in either direct or indirect coupling between glucose phosphorylation and insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118006     DOI: 10.2337/diabetes.49.12.2048

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.

Authors:  Michele L Markwardt; Andongfac Nkobena; Shi-Ying Ding; Mark A Rizzo
Journal:  Mol Endocrinol       Date:  2012-07-06

Review 2.  β-Cell dysfunction in chronic pancreatitis.

Authors:  M Sasikala; R Talukdar; P Pavan kumar; G Radhika; G V Rao; R Pradeep; C Subramanyam; D Nageshwar Reddy
Journal:  Dig Dis Sci       Date:  2012-03-02       Impact factor: 3.199

3.  Regulation of Glucokinase by Intracellular Calcium Levels in Pancreatic β Cells.

Authors:  Michele L Markwardt; Kendra M Seckinger; Mark A Rizzo
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

4.  Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells.

Authors:  Shi-Ying Ding; Andongfac Nkobena; Catherine A Kraft; Michele L Markwardt; Mark A Rizzo
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

Review 5.  The manifold roles of protein S-nitrosylation in the life of insulin.

Authors:  Hua-Lin Zhou; Richard T Premont; Jonathan S Stamler
Journal:  Nat Rev Endocrinol       Date:  2021-11-17       Impact factor: 47.564

Review 6.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

7.  Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.

Authors:  Shi-Ying Ding; Nicholas D Tribble; Catherine A Kraft; Michele Markwardt; Anna L Gloyn; Mark A Rizzo
Journal:  Mol Endocrinol       Date:  2009-11-24

8.  Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase.

Authors:  Megan A Rizzo; David W Piston
Journal:  J Cell Biol       Date:  2003-04-21       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.